Guolian Pharmaceutical Company ( China (Mainland))

Founded in 2000, Guolian Pharmaceutical Company is a multiple Hi-Tech pharmaceutical firm specialized in the research, development, sale and technology service of bulk drugs, intermediates, chemical medicine, traditional Chinese medicine, bio-chemical medicine and medical apparatus and instruments, etc. such as Pamabrom with cas registry number of 606-04-2, 4-Amino-2-(trifluoromethyl)benzonitrile with cas registry number of 654-70-6, Leucoson with cas registry number of 1950-36-3, 1-Bromo-2,4-dimethoxybenzene with cas registry number of 17715-69-4. All the activities are conducted in accordance with the GSP procedure. Therefore, the company passed the GSP authentication in October 2003.

Guolian also has founded the high technical Research and Development Base, one GSP Authenticated Standard Storehouse, and the marketing network in several dozens of provinces, municipalities and autonomous regions through the tremendous efforts of its highly competent team.

Guolian has set up the domestically leading Technical Platform such as sustained/controlled-released techniques, High-Bioavailability Pharmaceutical Techniques, micro-pellettechniques,Emulsification Techniques, chiral compounds systhesis techniques, etc. Several dozens of Certificates for new drugs have been issued, as well as more than thirty clinical certificates. The qualities of most products meet the standards of the pharmacopoeia in Europe and America. The production for most of the above-mentioned drugs has been industrialized.

Guolian devotes to serving the people with the products and professional knowledge to resolve the reproductive organs related health problems.